Biography:
Phani Satti, Director of Analytical Development at Veranova, L.P., has over 22 years of experience in pharmaceutical R&D, specializing in analytical method development, validation, impurity profiling, and GMP laboratory establishment. He has authored multiple peer-reviewed publications on nitrosamine impurities, stability-indicating methods, chiral separations, and nanomedicine, with his work cited internationally and influencing scientific practice and regulatory approaches. Phani is currently pursuing a Ph.D. in Analytical Chemistry and is committed to mentoring scientists, fostering innovation, and driving excellence in analytical R&D to support preclinical, clinical, and commercial pharmaceutical programs.
Title : Analytical methods based on liquid chromatography tandem mass spectrometry for the detection of genotoxic nitrosamine impurities